載入...
Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?
The past decade saw the advent of a number of promising biomarkers to detect pregnancies at risk for preeclampsia (PE), the foremost being those associated with an imbalance of angiogenic factors. In late pregnancy, these are useful for the detection of imminent cases of PE, while earlier they were...
Na minha lista:
| 發表在: | Expert Rev Mol Diagn |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Informa Healthcare
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4673513/ https://ncbi.nlm.nih.gov/pubmed/25774007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737159.2015.1025757 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|